Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells

被引:57
作者
Park, Sang Eun [1 ]
Park, Cheol [2 ]
Kim, Sun Hee [1 ]
Hossain, Mohammad Akbar [1 ]
Kim, Min Young [1 ]
Chung, Hae Young [1 ]
Son, Woo Sung [3 ]
Kim, Gi-Young [4 ]
Choi, Yung Hyun [2 ]
Kim, Nam Deuk [1 ]
机构
[1] Pusan Natl Univ, Res Inst Drug Dev, Dept Pharm, Program BK21, Pusan 609735, South Korea
[2] Dong Eui Univ, Coll Oriental Med, Dept Biochem, Pusan 614052, South Korea
[3] Sch Dent, Dept Orthodont, Pusan 602739, South Korea
[4] Jeju Natl Univ, Fac Appl Marine Sci, Cheju 690756, South Korea
关键词
Red ginseng; Human leukemia cells; Apoptosis; COX-2; Telomerase; BREAST-CANCER CELLS; PROTEOLYTIC CLEAVAGE; CARCINOMA CELLS; PHORBOL ESTER; CYCLOOXYGENASE-2; EXPRESSION; INHIBITION; GROWTH; IDENTIFICATION; ACTIVATION;
D O I
10.1016/j.jep.2008.10.038
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Aim of this study: Korean red ginseng (KRG, Panax ginseng C.A. Meyer Radix rubra) has been used to treat various diseases including cancer. However, the molecular mechanisms responsible for KRG extract induced apoptosis and telomerase inhibition remain unclear. Materials and methods: The hot water extract from KRG was used to evaluate the mechanism of induction of apoptosis in U937 human leukemia cells and its effects on cyclooxgenase-2 (COX-2) and telomerase activity. Results: KRG extract treatment to U937 cells resulted in growth inhibition and induction of apoptosis in a concentration-dependent manner as measured by hemacytometer counts, MTT assay, fluorescence microscopy, agarose gel electrophoresis and flow cytometry analysis. The increase in apoptosis was associated with the down-regulation of antiapoptotic Bcl-2, Bcl-X-L, and IAPs family members, and the activation of caspase-3. KRG extract treatment also decreased the expression levels of COX-2 and inducible nitric oxide synthase. Furthermore. KRG extract treatment progressively down-regulated the expression of human telomerase reverse transcriptase, a main determinant of the telomerase enzymatic activity, with inhibiting the expression of c-Myc in a concentration-dependent manner. Conclusions: These results provide important new insights into the possible molecular mechanisms of the anticancer activity of KRG extract. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:304 / 312
页数:9
相关论文
共 55 条
[11]  
Chui CH, 2006, ONCOL REP, V16, P1313
[12]   Reconstitution of telomerase activity combined with HPV-E7 expression allow human preadipocytes to preserve their differentiation capacity after immortalization [J].
Darimont, C ;
Zbinden, I ;
Avanti, O ;
Leone-Vautravers, P ;
Giusti, V ;
Burckhardt, P ;
Pfeifer, AMA ;
Macé, K .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (09) :1025-1031
[13]   Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen:: a closer look [J].
Davydov, M ;
Krikorian, AD .
JOURNAL OF ETHNOPHARMACOLOGY, 2000, 72 (03) :345-393
[14]   Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases [J].
Deveraux, QL ;
Leo, E ;
Stennicke, HR ;
Welsh, K ;
Salvesen, GS ;
Reed, JC .
EMBO JOURNAL, 1999, 18 (19) :5242-5251
[15]   Cyclooxygenase, NSAIDs, and colorectal cancer [J].
DuBois, RN ;
Smalley, WE .
JOURNAL OF GASTROENTEROLOGY, 1996, 31 (06) :898-906
[16]   UP-REGULATION OF CYCLOOXYGENASE-2 GENE-EXPRESSION IN HUMAN COLORECTAL ADENOMAS AND ADENOCARCINOMAS [J].
EBERHART, CE ;
COFFEY, RJ ;
RADHIKA, A ;
GIARDIELLO, FM ;
FERRENBACH, S ;
DUBOIS, RN .
GASTROENTEROLOGY, 1994, 107 (04) :1183-1188
[17]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[18]   Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-α and phorbol ester in human endothelial cells [J].
Eligini, S ;
Barbieri, SS ;
Cavalca, V ;
Camera, M ;
Brambilla, M ;
De Franceschi, M ;
Tremoli, E ;
Colli, S .
CARDIOVASCULAR RESEARCH, 2005, 65 (03) :683-693
[19]   Cyclooxygenase-2 promotes prostate cancer progression [J].
Fujita, H ;
Koshida, K ;
Keller, ET ;
Takahashi, Y ;
Yoshimito, T ;
Namiki, M ;
Mizokami, A .
PROSTATE, 2002, 53 (03) :232-240
[20]  
Gartel AL, 2002, MOL CANCER THER, V1, P639